ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 622579 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 622579; 2) Community: the network communities that were significantly associated with the response to NSC 622579; 3) Molecule: the relationships between components within communities and NSC 622579; 4) MDR: the compounds that were significantly associated with the NSC 622579.

NSC Compound Enrichment Correlation
NSC 703109 Null 0.0174989034030623 0.41812697
NSC 703117 Null 0.0174989034030623 0.4441258
NSC 710716 Null 0.0174989034030623 0.55650157
NSC 716951 Null 0.0174989034030623 0.54141663
NSC 719715 Null 0.0174989034030623 0.51385319
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0174989034030623 0.44002993
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0174989034030623 0.40525628
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.0174989034030623 0.42668899
NSC 740 Methotrexate 0.0174989034030623 0.42806125
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.0174989034030623 0.39219555
Total:130  Current:62    [First] [Prev] [Next] [Last]